KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Keytruda, […]
Read more
Inappropriate pain management after surgery is a major cause of the opioid crisis
Targets to eliminate pain after surgery have driven increases in the use of opioids, and are a major cause of the opioid crisis in the USA, Canada and other countries. […]
Read more
The ‘painless woman’ helps us see how anxiety and fear fit in the big picture of pain
Imagine a life without pain. No toothache. No period pain. No arthritis. A woman who feels no pain has been in the news recently, linked to a case study published […]
Read more
Young child goes to ED for medicine poisoning every 10 minutes
(HealthDay)—The number of children younger than age 6 years treated at U.S. emergency departments for medicine poisonings has declined in recent years, but there were still nearly 52,000 cases in […]
Read more
Opioid crisis: Only a US phenomenon?
Addiction to prescription opioids has reached a crisis level in the United States. Now the drug is causing concern across the Atlantic. Researchers from Denmark, Norway and Sweden urge caution […]
Read more
FDA Grants Genentech’s Tecentriq in Combination With Abraxane Accelerated Approval for People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer
South San Francisco, CA — March 8, 2019 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) […]
Read more
Lilly to sell cheaper version of top-selling insulin Humalog
Eli Lilly is offering a half-price version of its top-selling insulin Humalog as drugmakers face growing pressure to control prices. The drugmaker says it will introduce a version of the […]
Read more
Peer support, healing hands may curb prescription opioid misuse
A program offering group support, acupuncture, mindfulness, massage and gentle exercise may help prevent patients on prescription opioids from spiraling down to drug misuse, overdose and death, according to a […]
Read more
UK sales of Xanax and other prescription psychiatric drugs increasing via the darknet
Sales of prescription psychiatric drugs such as Xanax and diazepam via darknet online drug markets have increased in the UK at an alarming rate, according to new research by the […]
Read more
Sanofi and Regeneron Offer Praluent (alirocumab) at a New Reduced U.S. List Price
BRIDGEWATER, N.J. and TARRYTOWN, N.Y., Feb. 11, 2019 /PRNewswire/ — Praluent (alirocumab) will be made available at a new reduced U.S. list price of $5,850 annually, a 60% reduction from […]
Read more